Osilodrostat, also known as LCI699, is a potent inhibitor of 11β-hydroxylase, the enzyme which catalyzes the final step of cortisol synthesis. LCI699 may thus be a potential new treatment for all forms of Cushing's syndrome. Current evidence indicates that the novel aldosterone inhibitor LCI699 is an effective and well-tolerated antihypertensive agent that lowers plasma aldosterone concentration and produces a mild ACTH-stimulated cortisol response suppressive effect.
Tags: buy Osilodrostat | purchase Osilodrostat | Osilodrostat cost | order Osilodrostat | Osilodrostat chemical structure | Osilodrostat in vivo | Osilodrostat in vitro | Osilodrostat formula | Osilodrostat molecular weight